Bob Burrows | Vice President of Investor Relations |
Bob Kramer | President and Chief Executive Officer |
Rich Lindahl | Chief Financial Officer |
Brandon Folkes | Cantor |
Jessica Fye | JPMorgan |
Joichi Sakai | Singular Research |
Thank you for standing by, and welcome to the Emergent BioSolutions Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Bob Burrows, Vice President of Investor Relations.